Company Filing History:
2 out of 4,770 
1 out of 9 
1 out of 1 Years Active: 1997
Title: Eitan Friedman: Innovator in Steroid Hormone Receptor Research
Introduction
Eitan Friedman is a notable inventor based in Wynnewood, Pennsylvania. He has made significant contributions to the field of steroid hormone receptor research, holding two patents that showcase his innovative work. His research focuses on the NER receptor, a novel member of the steroid hormone receptor superfamily.
Latest Patents
Friedman's latest patents include a method for finding transcription activators of the NER steroid hormone. This patent details the preparation of the NER receptor through cDNA cloning from a human osteosarcoma SAOS-2/B10 cell library. It discloses the complete sequence of human NER complementary DNA, expression systems, and an assay using the COS expression system. This assay is designed to identify agents that activate transcription mediated by the NER receptor, which can be useful for enhancing the activity of modulators of G-protein coupled receptors. Another significant patent involves the treatment of Alzheimer's disease using 5-(tetradecyloxy)-2-furan-carboxylic acid, leveraging the novel receptor NER TOFA.
Career Highlights
Throughout his career, Eitan Friedman has worked with prominent organizations such as Merck & Company, Inc. and The Medical College of Pennsylvania. His experience in these institutions has contributed to his expertise in the field of pharmaceutical research and development.
Collaborations
Friedman has collaborated with notable colleagues, including M. Katharine Holloway and Gideon A. Rodan. These collaborations have further enriched his research and innovation in steroid hormone receptors.
Conclusion
Eitan Friedman is a distinguished inventor whose work in steroid hormone receptor research has led to valuable patents and advancements in the treatment of diseases like Alzheimer's. His contributions continue to impact the field significantly.